Latest Funding News

Evion Group confirms high-grade fluorspar assays up to 88.15% CaF2 at its Carp Project in Nevada, validating a large, near-surface mineralised system. The company plans an extensive exploration program to capitalise on the US critical minerals demand.

Revolver Resources has secured critical contracts and completed infrastructure upgrades at its Dianne Copper Mine Project, moving closer to a Final Investment Decision and first copper output within a year.

Desert Metals has expanded its Tiogo gold anomaly at Tengrela South, Côte d'Ivoire, by over 3km northwards, unveiling a new high-priority target ready for drilling.

Pacific Edge reported a steep 47% revenue drop in FY26 following Medicare coverage loss but secured a draft Medicare policy covering its Cxbladder tests and raised NZ$25.4 million to fuel growth and commercial execution.

Radius Residential Care has syndicated its bank debt, boosting facility limits by NZD 30 million and cutting financing costs by 65 basis points to support its growth plans, including a new care home acquisition and development projects.

TruScreen Group has secured NZ$1.82 million through an oversubscribed placement, underscoring investor confidence amid its global cervical screening expansion. The company also announced a renounceable rights issue and attaching options, both subject to shareholder approval.

EROAD reported flat group revenue of NZD 195.2 million for FY26, driven by strong Australian growth and steady New Zealand performance, offset by a North American decline and a hefty goodwill impairment.

Alternative Investment Trust (AIQ) has issued 7.39 million units at A$1.38 each, raising A$10.2 million from wholesale investors without a product disclosure statement. The capital raise aligns with AIQ’s adjusted net tangible asset value and complies with Corporations Act requirements.

Gumtree Australia Markets has refinanced its Commonwealth Bank loan, cutting quarterly repayments and extending the facility to November 2027, freeing up cashflow to support sales growth.

Vectus Biosystems has secured $791,000 through a placement to accelerate its lead fibrosis drug VB0004's Phase IB clinical trial and advance other drug candidates.

Orion Minerals has secured $15.4 million in a placement to accelerate development at its Prieska and Okiep copper projects in South Africa, paving the way for its transition to a copper producer.

Mayne Pharma has been awarded $13.27 million in legal costs by the Supreme Court of New South Wales after successfully defending against Cosette Pharmaceuticals’ claims tied to a terminated acquisition deal.